New York State Common Retirement Fund Sesen Bio, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.38 - $0.89 $45,904 - $107,512	-120,800 Reduced 98.53%	1,806 $1,000
Q1 2022 May 05, 2022	BUY	$0.58 - $0.86 $150 - $222	259 Added 0.21%	122,606 $74,000
Q4 2021 Feb 02, 2022	SELL	$0.73 - $1.28 $87 - $153	-120 Reduced 0.1%	122,347 $100,000
Q3 2021 Nov 02, 2021	SELL	$0.77 - $4.91 $18,428 - $117,511	-23,933 Reduced 16.35%	122,467 $97,000
Q2 2021 Aug 02, 2021	BUY	$2.18 - $4.66 $319,152 - $682,224	146,400 New	146,400 $676,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.